Focus Partners Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$378M Sell
1,488,289
-114,986
-7% -$26.8M 0.39% 52
2026
Q1
$392M Buy
1,603,275
+4,337
+0.3% +$1.01M 0.44% 50
2025
Q4
$328M Buy
1,598,938
+303,974
+23% +$60.1M 0.37% 55
2025
Q3
$240M Buy
1,294,964
+37,682
+3% +$6.46M 0.39% 55
2025
Q2
$192M Buy
1,257,282
+63,904
+5% +$9.82M 0.42% 49
2025
Q1
$198M Buy
1,193,378
+30,625
+3% +$4.79M 0.5% 44
2024
Q4
$168M Buy
1,162,753
+268,294
+30% +$41.6M 0.44% 45
2024
Q3
$145M Sell
894,459
-686,677
-43% -$109M 0.46% 43
2024
Q2
$231M Buy
1,581,136
+1,143,545
+261% +$170M 0.78% 26
2024
Q1
$69.2M Buy
437,591
+256,748
+142% +$40.9M 0.56% 38
2023
Q4
$28.3M Buy
+180,843
New +$27.7M 0.37% 70

Other funds holding JNJ

Focus Partners Wealth's JNJ Position: Q2 2026 in Review

Focus Partners Wealth reduced its Johnson & Johnson (JNJ) stake by 7.2% in Q2 2026, selling an estimated $26.8M and leaving 1,488,289 shares worth $378M. The position accounts for 0.39% of the portfolio, ranked #52.

Focus Partners Wealth first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $392M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Focus Partners Wealth held 1,488,289 shares of Johnson & Johnson worth $378M as of Q2 2026.
  • Focus Partners Wealth sold 114,986 Johnson & Johnson shares in Q2 2026, an estimated $26.8M.
  • Johnson & Johnson made up 0.39% of Focus Partners Wealth's portfolio in Q2 2026, its #52 holding.
  • Focus Partners Wealth first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Johnson & Johnson position peaked at $392M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.